ATE328583T1 - Hochdosierte liposomale aerosolformulierung - Google Patents

Hochdosierte liposomale aerosolformulierung

Info

Publication number
ATE328583T1
ATE328583T1 AT04009645T AT04009645T ATE328583T1 AT E328583 T1 ATE328583 T1 AT E328583T1 AT 04009645 T AT04009645 T AT 04009645T AT 04009645 T AT04009645 T AT 04009645T AT E328583 T1 ATE328583 T1 AT E328583T1
Authority
AT
Austria
Prior art keywords
high dose
compounds
phospholipid
aerosol composition
liposome aerosol
Prior art date
Application number
AT04009645T
Other languages
English (en)
Inventor
Clifford J Waldrep
Vernon Knight
Melanie B Black
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/731,605 external-priority patent/US5958378A/en
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Application granted granted Critical
Publication of ATE328583T1 publication Critical patent/ATE328583T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04009645T 1996-07-03 1997-07-02 Hochdosierte liposomale aerosolformulierung ATE328583T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67565496A 1996-07-03 1996-07-03
US08/731,605 US5958378A (en) 1996-07-03 1996-10-16 High dose liposomal aerosol formulations containing cyclosporin A or budesonide

Publications (1)

Publication Number Publication Date
ATE328583T1 true ATE328583T1 (de) 2006-06-15

Family

ID=27101390

Family Applications (2)

Application Number Title Priority Date Filing Date
AT97933287T ATE268163T1 (de) 1996-07-03 1997-07-02 Hochdosierte liposomale aerosolformulierung
AT04009645T ATE328583T1 (de) 1996-07-03 1997-07-02 Hochdosierte liposomale aerosolformulierung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT97933287T ATE268163T1 (de) 1996-07-03 1997-07-02 Hochdosierte liposomale aerosolformulierung

Country Status (10)

Country Link
EP (1) EP0959874B1 (de)
JP (1) JP2001524930A (de)
CN (1) CN1094345C (de)
AT (2) ATE268163T1 (de)
AU (1) AU732124B2 (de)
CA (1) CA2259185C (de)
DE (2) DE69736083T2 (de)
NZ (1) NZ333497A (de)
TW (1) TW497974B (de)
WO (1) WO1998000111A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417172B1 (en) * 1995-06-05 2002-07-09 Eisai Co., Ltd. Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
US5863910A (en) * 1996-01-12 1999-01-26 Bolonick; Joel Treatment of chronic inflammatory disorders of the gastrointestinal tract
US6090407A (en) * 1997-09-23 2000-07-18 Research Development Foundation Small particle liposome aerosols for delivery of anti-cancer drugs
US7348025B2 (en) 1997-09-23 2008-03-25 Research Development Foundation Small particle liposome aerosols for delivery of anticancer drugs
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US20020006901A1 (en) * 1999-02-05 2002-01-17 Aldo T. Iacono Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
AU763945B2 (en) * 1999-06-04 2003-08-07 Skyepharma Inc. Oil-core compositions for the sustained release of hydrophobic drugs
IL150027A0 (en) * 1999-12-04 2002-12-01 Res Dev Foundation Carbon dioxide enhancement of inhalation therapy
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
AU2003237863A1 (en) * 2002-05-20 2003-12-12 Research Development Foundation Aerosol drug inhibition of lung metastases
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
JP5846711B2 (ja) 2005-06-09 2016-01-20 メダ アーベー 炎症性疾患の治療のための方法及び組成物
DE102006051512A1 (de) 2005-12-06 2007-06-14 Pari GmbH Spezialisten für effektive Inhalation Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin
CN101502484B (zh) * 2006-12-26 2011-04-20 济南康泉医药科技有限公司 同载糖皮质激素和化疗药物的抗癌缓释剂
MX2010005100A (es) * 2007-11-09 2010-11-12 Map Pharmaceuticals Inc Metodos para administrar formulaciones de corticoesteroides.
PE20130045A1 (es) 2010-03-12 2013-01-28 Berg Pharma Llc FORMULACIONES INTRAVENOSAS DE COENZIMA Q10 (CoQ10) Y METODOS DE USO DE LAS MISMAS
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
EP2598128B1 (de) 2010-07-28 2018-03-28 Life Technologies Corporation Azidhaltige antivirale verbindungen
IN2013MN00329A (de) * 2010-08-05 2015-05-29 Piramal Entpr Ltd
CN102008713B (zh) * 2010-12-02 2012-10-24 深圳海王药业有限公司 环孢素a前体脂质体、药物组合物及其制备方法
KR102058256B1 (ko) 2011-06-17 2020-01-22 버그 엘엘씨 흡입성 약제학적 조성물들
GB201114332D0 (en) 2011-08-19 2011-10-05 Nufarm Uk Ltd Novel inhibitor compositions and methods of use
KR20140129054A (ko) 2012-01-26 2014-11-06 라이프 테크놀로지스 코포레이션 바이러스의 감염성을 증가시키는 방법
EP3813788A1 (de) 2018-06-27 2021-05-05 Breath Therapeutics GmbH Pharmazeutische zusammensetzungen in lyophilisierter form
WO2020002351A1 (en) * 2018-06-27 2020-01-02 Breath Therapeutics Gmbh Inhalable compositions comprising macrocyclic immunosuppressants
EA202092892A1 (ru) * 2018-12-04 2021-05-27 Брес Терапьютикс Гмбх Ингаляционные композиции, содержащие макроциклические иммуносупрессанты

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8403905D0 (sv) * 1984-07-30 1984-07-30 Draco Ab Liposomes and steroid esters
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
IE63869B1 (en) * 1986-11-06 1995-06-14 Res Dev Foundation Aerosols containing liposomes and method for their preparation
US5049388A (en) * 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
MX9201782A (es) * 1991-04-19 1992-10-01 Sandoz Ag Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene.
DE4203306A1 (de) * 1992-02-06 1993-08-12 Ig Spruehtechnik Gmbh Asthma oder pulmonal-aerosolzubereitungen mit lecithin
SA95160463B1 (ar) * 1994-12-22 2005-10-04 استرا أكتيبولاج مساحيق للاستنشاق

Also Published As

Publication number Publication date
AU732124B2 (en) 2001-04-12
DE69736083T2 (de) 2006-12-28
NZ333497A (en) 2000-06-23
EP0959874B1 (de) 2004-06-02
TW497974B (en) 2002-08-11
CA2259185C (en) 2009-12-15
CN1224347A (zh) 1999-07-28
WO1998000111A1 (en) 1998-01-08
AU3650897A (en) 1998-01-21
DE69729391T2 (de) 2005-06-02
JP2001524930A (ja) 2001-12-04
CA2259185A1 (en) 1998-01-08
CN1094345C (zh) 2002-11-20
EP0959874A4 (de) 1999-12-22
EP0959874A1 (de) 1999-12-01
DE69729391D1 (de) 2004-07-08
ATE268163T1 (de) 2004-06-15
DE69736083D1 (de) 2006-07-20

Similar Documents

Publication Publication Date Title
ATE268163T1 (de) Hochdosierte liposomale aerosolformulierung
CA1223819A (en) Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
HUP0303719A2 (hu) Mitoxantron hatóanyag-tartalmú liposzómás gyógyszerkészítmények és eljárás az előállításukra
NO944957D0 (no) Galenisk blanding, fremgangsmåte for fremstilling av denne, samt anvendelse derav
NZ509418A (en) Pharmaceutical formulations for aerosols with two or more active substances
CA2033725A1 (en) Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
IL91656A0 (en) Pharmaceutical composition containing a benzodiazepine derivative
WO1998058629A3 (en) Preparation of pharmaceutical compositions
CA2301017A1 (en) Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
KR890700036A (ko) 비내 투여용 제제 및 그 제조방법
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
BR9912694A (pt) Composto para preparar medicamento de administração pulmonar
KR960028918A (ko) 국소용 약제학적 조성물
KR960700061A (ko) 니코틴 의존상태 치료를 위한 약리학적 제형 (pharmaceutical composition for treating nicotine dependence)
WO1998013024A3 (en) Hyaluronic drug delivery system
IL117889A0 (en) Pharmaceutical compositions containing lipophilic compounds
CA2320072A1 (en) Erythropoietin liposomal dispersion
DE69939180D1 (de) Pharmazeutische zubereitungen zur externen anwendung, die nicht steroidale antiinflammatorische und analgetische wirkstoffe enthalten
MY111841A (en) Injectable liposomal pharmaceutical preparations
ITMI921831A1 (it) Composizioni farmaceutiche in forma di microemulsioni o di dispersioni liposomiali bioadesive per la somministrazione transmucosale di sostanze peptidiche e di proteine farmacologicamente attive
CA2348474A1 (en) Pharmaceutically active composition and dispensing device
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
IT1260155B (it) Uso terapeutico della fosforil-l-serina-n-acil-sfingosina
AU2809697A (en) Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
BR9917006A (pt) ácido niflúmico lipossÈmico - medicamentoantiinflamatório transdérmico

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties